Compositions and methods for treating crohn's disease and related conditions and infections
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A Crohn's disease, composition technology, applied in the direction of drug combination, application, pharmaceutical formulation, etc., can solve the problem of delay in curing time, taking weeks or months, etc.
Inactive Publication Date: 2015-04-22
高拉夫·阿格拉沃尔
View PDF26 Cites 8 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Anti-Mycobacterium paratuberculosis (anti-MAP) therapy can successfully cure Crohn's diseas
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0158] Example 1: Treatment of Crohn's associated fistula by administering the "triple combination therapy" of the present invention Exemplary treatment
[0159] A 32-year-old (yr) man with a 3-year history of Crohn’s disease (CD) presented with diarrhea, urgency, perianal tenderness, and discharge from a high left posterior fistula and right anterior fistula. With a'drain line' in place. The entire colon is inflamed, with Crohn's ulcer destroying the colonic haustration area. During the combination therapy, the'leakage line' is removed. At the 6th week, it was confirmed by MRI that the two fistulas were completely healed, with only scarring. Inflammation markers are normal and the patient continues anti-MAP therapy.
[0160] A 32-year-old woman with a 22-year history of CD was complicated by a rectal-vaginal fistula. She had severe pain during intercourse and had intestinal gas passing into the vagina during bowel emptying. The patient also reported frequent and urgent bowel...
Embodiment 2
[0161] Example 2: Treatment of Crohn's associated fistula by administering the "triple combination therapy" of the present invention Exemplary treatment
[0162] In an alternative embodiment, the treatment of the invention for patients with confirmed CD (+ / - fistula) comprises a combination of the following:
[0163] - Infliximab (5mg / kg, as an intravenous induction regimen at 0, 2 and 6 weeks (and then if necessary, a 5mg / kg maintenance regimen every 8 weeks, typically, the number of administrations is 3 to 9 Within the scope).
[0164] -Continuously starting from week 0 Anti-MAP therapy (Typically maintained for 3 months to 2 years or more).
[0165] In an alternative embodiment, in adults, this would be clofazimine, 100 mg / day; rifabutin, 450-600 mg / day; clarithromycin, 1 g / day; and another 400-800 Metronidazole at mg / day or ethambutol at 800 mg / day or pyrazinamide at 500 mg to 2 gm, depending on the adverse effects.
[0166] In an alternative embodiment, in children, this woul...
Embodiment 3
[0168] Example 3: Treatment of Crohn's associated fistula by administering the "triple combination therapy" of the present invention Exemplary treatment
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
In alternative embodiments, the invention provides a “triple combination” therapy for treating, ameliorating and preventing Crohn's Disease (or Crohn syndrome, terminal or distal ileitis or regional enteritis) or related disorders and conditions in mammals, such as paratuberculosis in mammals, or Johne's disease, including genetically-predisposed and chronic disorders, where the microbial or bacterial flora of the bowel is at least one causative or symptom-producing factor; and compositions for practicing same. In alternative embodiments, methods and compositions of the invention comprise or comprise use of therapies, medications, formulations and pharmaceuticals comprising active agents that can suppress or eradicate the microbiota super-infection that causes Crohn's Disease or paratuberculosis infection in mammals. In alternative embodiments, the methods and uses of the invention for treating, ameliorating and preventing Crohn's Disease and complications of Crohn's Disease, or related disorders and conditions in mammals, such as paratuberculosis in mammals, or Johne's disease, comprises administration to an individual (human or mammal) in need thereof: (1) an anti-TNFα composition, or a composition capable of down-modulating TNFα activity; (2) a Hyperbaric Oxygen Treatment, or HBOT; and (3) an anti-Mycobacterium avium sub species paratuberculosis (MAP) (an anti-MAP) agent, composition or therapy.
Description
Technical field [0001] The present invention generally relates to medicine as well as gastroenterology, pharmacology and microbiology. In an alternative embodiment, the present invention provides a method for treating, ameliorating, and preventing Crohn's disease (or Crohn's syndrome, terminal or distal ileitis or limitation of mammals) Enteritis) or "triple combination" therapy for related disorders and conditions, such as paratuberculosis in mammals, or Johne's disease, including genetic predisposition disorders and chronic disorders, in which the intestinal The microbe or bacterial flora is at least one causative factor or symptom producing factor; and a composition for implementing the therapy. In alternative embodiments, the methods and compositions of the present invention include or include the use of an active agent capable of inhibiting or eradicating the double infection of the microbiota that causes Crohn's disease or paratuberculosis infection in mammals, medicament...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more